Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-571-6 | CAS number: 108-31-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- sub-chronic toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
- Report date:
- 1981
- Reference Type:
- publication
- Title:
- A 6-month multispecies inhalation study with maleic anhydride
- Author:
- Short D.R.et al.
- Year:
- 1 988
- Bibliographic source:
- Fundamental and Applied Toxicology 10, 517-524
- Reference Type:
- review article or handbook
- Title:
- Maleic Anhydride and Maleic Acid, SIDS Initial Assessment Report For SIAM 18
- Author:
- OECD SIDS
- Year:
- 2 004
- Bibliographic source:
- OECD SIDS Initial Assessment Report For SIAM 18, Paris, France, 20-23 April 2004
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Evaluation of maleic anhydride toxicity in rats, hamsters and monkeys after 6 months of inhalation administration.
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Maleic anhydride
- EC Number:
- 203-571-6
- EC Name:
- Maleic anhydride
- Cas Number:
- 108-31-6
- Molecular formula:
- C4H2O3
- IUPAC Name:
- 2,5-dihydrofuran-2,5-dione
- Details on test material:
- - Name of test material (as cited in study report): Maleic anhydride
- Physical state: white briquettes
- Analytical purity: > 99%
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: CD
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River
- Weight at study initiation: 230-310 g (males); 174-200 g (females)
- Age at study initiation: about 8 weeks
- Housing: single
- Diet: ad libitum (except during exposure)
- Water: ad libitum (except during exposure)
- Acclimation period: at least 2 weeks
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: 15 m² cubical stainless-steel and glass chambers with pyramidal tops
- System of generating particulates/aerosols: Atmospheres containing the test material were generated by heating maleic anhydride, which has a melting point of 53°C, and by transporting vapors from the melt to the chambers with a stream of nitrogen gas. The overall quantity af maleic anhydride vaporized was determined by weighing the "boat" containing maleic anhydride prior to exposure and upon recrystallization of the compound after exposure.
TEST ATMOSPHERE
- Brief description of analytical method used: Chamber concentrations were sampled at least three times per day
- Samples taken from breathing zone: yes - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Concentrations in the chamber (total maleic; i .e ., maleic anhydride plus maleic acid) were monitored by drawing samples through Tenax columns and by quantifying the retained material, after thermal desorption into a nitrogen steam, using a gas chromatograph equipped with a flame ionization detector and a stainless-steel column packed with 1 .5% OV-l01 on 100-120 Chromosorb G-HP. The range of column and detector temperatures was 115 to 150°C and 205 to 220°C, respectively.
- Duration of treatment / exposure:
- 6-months / 132 or 133 exposures
- Frequency of treatment:
- 6 hours per day, 5 days per week
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/m³ air (analytical)
- Dose / conc.:
- 1.1 mg/m³ air (analytical)
- Dose / conc.:
- 3.3 mg/m³ air (analytical)
- Dose / conc.:
- 9.8 mg/m³ air (analytical)
- No. of animals per sex per dose:
- 15
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- - Fasting period before blood sampling for clinical biochemistry: 16- hour fasting period
- Positive control:
- no
Examinations
- Observations and examinations performed and frequency:
- DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: before and after each exposure
BODY WEIGHT: Yes
- Time schedule for examinations: twice a week for the initial 2 months and weekly thereafter
OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: monthly intervals
- Dose groups that were examined: on all test animals.
HAEMATOLOGY: Yes
- Animals fasted: Yes
- How many animals: 5 rats/sex/group from the control and high-exposure groups at 3 months and 5 rats/sex/group at 6 months
- Parameters checked: hemoglobin, hematocrit, total erythrocyte count, and total and differential leucocyts count
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: at 3 and 6 months
- How many animals: 5 rats/sex/group from the control and high-exposure groups at 3 months and 5 rats/sex/group at 6 months
- Parameters checked: glucose, urea nitrogen, serum glutamic pyruvic transaminase activity, serum alkaline phosphatase activity, carbon dioxide, erythrocyte and plasma cholinesterase activity, and terminal brain cholinesterase activity
URINALYSIS: Yes
- Time schedule for collection of urine: 5 rats/sex/group from the control and high-exposure groups at 3 months and 5 rats/sex/group at 6 months
- Metabolism cages used for collection of urine: Yes
- Parameters checked: volume, pH, specific gravity, description of color and appearance, qualitative tests for albumin, glucose, bilirubin, ketones and occult blood and microscopic examination of the sediment
- Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes (on the control and high-exposure groups) - Statistics:
- All statistical analyses compared the treatmant groups with the control group, by sex. Not all parameters were statistically evaluated at all intervals. Some parameters at some intervals were evaluated statistically after a review of the data indicated that a possible exposure related effec may have been present. The hematological, biochemical and urinalysis parameters (terminal) and absolute and relative organ weights (terminal) were compared by analysis of variance (one-way classification), Bartlett's test for homogeneity of variances and the appropriate t-test (for equal or unequal variances) as described by Steel and Torrie using Dunnett's multiple comparison tables to judge significance of differences.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- For further details, see section below "Details on results".
- Mortality:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- For further details, see section below "Details on results".
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- no effects observed
- Haematological findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- For further details, see section below "Details on results".
- Clinical biochemistry findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- For further details, see section below "Details on results".
- Urinalysis findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- For further details, see section below "Details on results".
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, non-treatment-related
- Description (incidence and severity):
- For further details, see section below "Details on results".
- Gross pathological findings:
- no effects observed
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- For further details, see section below "Details on results".
- Histopathological findings: neoplastic:
- not examined
- Details on results:
- CLINICAL SIGNS AND MORTALITY: Survival was >90% in all groups. Nasal and ocular irritations were observed at all maleic anhydride-exposed animals during the study. High-exposure rats exhibited a red-tinged nasal discharge, isolated cases of ocular discharge and sneezing. These effects were less severe in animals from the low- and mid-exposure groups.
BODY WEIGHT AND WEIGHT GAIN: Statistically significant reductions in body weights were observed in the male rats in the mid-exposure group on days 78, 92, 106, and 127; and in the high-exposure group on days 40 through 189 (p<0.05). Statistically significant reductions in body weights were observed in the female rats in the mid-exposure groups on days 54, 127, 141, 148, 155, an 156; and in the high-exposure group on days 37, 47, 57, 71, 85-176, and 189 [<10%, (p<0.05)]. However, at the end of the treatment period, terminal body weights were reduced only for male rats from the high-exposure group. There were no statistically significant effect on body weight at the low-exposure group for either sex of rat.
HAEMATOLOGY: significant decrease in monocyte count in high dose male rats; no biological significance was attributed to these values since they were within the normal range af variation
CLINICAL CHEMISTRY: Clinical chemistry results indicated a few differences which were statistically different from the control values; however, none of these differences were considered to be treatment related or consistent in both sexes. These differences were:
- glucose was reduced in males (- 9%) and increased in females (+ 17%) of the mid dose group after 6 months while both sexes of the high dose group had reduced values after 3 months (-18% and -21%, respectively);
- serum CO2 levels were slightly elevated in the high dose males after 6 months (+ 11%);
- urea nitrogen was slighly increased in high dose females after 6 months (+ 26%);
- red blood cell cholinesterase activity was reduced in mid dose males at 6 months (-17%) and brain cholinesterase was increased in mid (+ 27%) and high dose males (+ 21%) at 6 months
URINALYSIS: Female rats in the low-dose group had a significantly reduced urine volume (- 59%) with an increased specific gravity (+ 3%). These observations were not dose related and thus not considered related to treatment.
ORGAN WEIGHTS: Organ weight changes were observed in rats (8 of 9 tissues weighed). The only changes present in both the mid- and high-exposure groups were increased relative pituitary weight in female rats (+ 23%/+ 30%), increased relative adrenal weight (females: + 28%/36%; males: + 19% in the high-exposure group) and reduced absolute (- 26%/- 28%) and relative thyroid weight (- 24%/- 20%) in male rats. Since the histopathology data did not provide evidence of tissue damage, these changes were not considered to be related to treatment.
HISTOPATHOLOGY: NON-NEOPLASTIC: Hyperplastic changes in the nasal tissues, which ranged in grade of severity from trace to mild, were present in all maleic anhydride exposed rats. Both the incidence and grade appeared to be exposure-related. Metaplastic changes in the nasal tissues were present in rats at all exposure levels and the incidence increased in a nonlinear fashion. Rats at all exposure levels exhibited a focal to multifocal infiltration of the nasal epithelium with neutrophils and eosinophils graded as trace to mild. A luminal exudate was present only on one and three males from the mid and high exposure groups, respectively. These changes in the nasal passages were indicative of irritation and judged to be reversible.
The only other histopathological change that was statistically significant (p < 0.05) relative to control animals was an increased amount of hemosiderin pigment in the red pulp from spleens of female rats in the high-exposure group.
Effect levels
open allclose all
- Dose descriptor:
- NOAEC
- Remarks:
- (systemic)
- Effect level:
- 3.3 mg/m³ air
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: temporarily reduced body weight in both sexes, not considered as adverse effect
- Dose descriptor:
- LOAEC
- Remarks:
- (systemic)
- Effect level:
- 9.8 mg/m³ air
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: reduced body weight in both sexes, increased amount of hemosiderin pigment in the red pulp from spleens of female rats
- Dose descriptor:
- LOAEC
- Remarks:
- (local)
- Effect level:
- 1.1 mg/m³ air
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: nasal and ocular irritations, discharges, hyperplastic and metaplastic changes in the nasal tissue, focal to-multiofocal infiltration of the nasal epithelium
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Table 1: Body weights of male and female rats exposed to atmospheres containing maleic anhydride
Total maleic (mg/m³) | ||||||||
0 | 1.1 | 3.3 | 9.8 | |||||
Month | M | F | M | F | M | F | M | F |
0 | 268a | 188 | 269 | 187 | 267 | 187 | 269 | 185 |
1 | 385 | 252 | 374 | 250 | 372 | 247 | 371 | 251 |
2 | 423 | 279 | 416 | 275 | 400 | 265 | 395b | 263b |
3 | 467 | 300 | 446 | 293 | 437b | 285 | 417b | 276b |
4 | 480 | 312 | 471 | 303 | 456 | 293 | 430b | 286b |
5 | 500 | 326 | 495 | 318 | 480 | 302b | 448b | 294b |
6 | 526 | 342 | 524 | 332 | 510 | 320 | 482b | 320 |
a Mean gram/rat for rats/group
b Significantly different from control.
Table 2: Histopathological observations in nasal tissue from rats exposed to atmospheres containing maleic anhydride
Total maleic (mg/m³) | ||||
Histopathological observation | 0 | 1.1 | 3.3 | 9.8 |
Mucosa epithelial hyperplasia focal/multifocal, septum/ turbinates | ||||
M | 0/0a | 13/40 | 7/93 | 0/80 |
F | 0/0 | 40/33 | 27/67 | 0/93 |
Mucosa, squamous metaplasia focal/ multifocal, septum/turbinates | ||||
M | 0b | 13 | 13 | 73 |
F | 0 | 0 | 13 | 87 |
a Perrcentage of animals with trace grade/percentage of animals with mild grade . Tissues from 15 rats/sex/group were examined .
b Percentage of animals with observation . Tissues from 15 rats/sex/group were examined.
Applicant's summary and conclusion
- Conclusions:
- In a 6-month inhalation study performed with rats, test item related effects on body weight and local effects in the respiratory tract were observed. Based on the results, the NOAEC (systemic) is considered to be 3.3 mg/m³ air and the LOAEC (local) 1.1 mg/m³ air.
- Executive summary:
In a 6 -month inhalation toxicity study maleic anhydride was administered to 15 rats/sex/concentration by whole body exposure at concentrations of 0, 1.1, 3.3 or 9.8 mg/m³ air (analytical) for 6 hours per day, 5 days/week for a total of 6 months.
Nasal and ocular irritations were observed at all maleic anhydride-exposed animals during the study. High-exposure rats exhibited a red-tinged nasal discharge, isolated cases of ocular discharge and sneezing. These effects were less severe in animals from the low- and mid-exposure groups.Then, statistically significant reductions in body weights were observed in the male rats in the mid-exposure group on days 78, 92, 106, and 127; and in the high-exposure group on days 40 through 189 (p<0.05). Statistically significant reductions in body weights were observed in the female rats in the mid-exposure groups on days 54, 127, 141, 148, 155, an 156; and in the high-exposure group on days 37, 47, 57, 71, 85-176, and 189 [<10%, (p<0.05)]. However, at the end of the treatment period, terminal body weights were reduced only for male rats from the high-exposure group. There were no statistically significant effect on body weight at the low-exposure group for either sex of rat. Significant decrease in monocyte count in high dose male rats; however, no biological significance was attributed to these values since they were within the normal range af variation. Furthermore, clinical chemistry results indicated a few differences which were statistically different from the control values; however, none of these differences were considered to be treatment related or consistent in both sexes. Female rats in the low-dose group had a significantly reduced urine volume (- 59%) with an increased specific gravity (+ 3%). These observations were not dose related and thus not considered related to treatment.
Organ weight changes were observed in rats (8 of 9 tissues weighed). The only changes present in both the mid- and high-exposure groups were increased relative pituitary weight in female rats (+ 23%/+ 30%), increased relative adrenal weight (females: + 28%/36%; males: + 19% in the high-exposure group) and reduced absolute (- 26%/- 28%) and relative thyroid weight (- 24%/- 20%) in male rats. Since the histopathology data did not provide evidence of tissue damage, these changes were not considered to be related to treatment.
Hyperplastic changes in the nasal tissues, which ranged in grade of severity from trace to mild, were present in all maleic anhydride exposed rats. Both the incidence and grade appeared to be exposure-related. Metaplastic changes in the nasal tissues were present in rats at all exposure levels and the incidence increased in a nonlinear fashion. Rats at all exposure levels exhibited a focal to multifocal infiltration of the nasal epithelium with neutrophils and eosinophils graded as trace to mild. A luminal exudate was present only on one and three males from the mid and high exposure groups, respectively. These changes in the nasal passages were indicative of irritation and judged to be reversible. The only other histopathological change that was statistically significant (p < 0.05) relative to control animals was an increased amount of hemosiderin pigment in the red pulp from spleens of female rats in the high-exposure group.
The NOAEC (systemic) is 3.3 mg/m³ based on the transient reduced body weight. The LOAEC (local) is 1.1 mg/m³ air based on the local effects in the respiratory tract observed at all applied concentration levels.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.